Boston Biomedica
This article was originally published in The Gray Sheet
Executive Summary
510(k) clearance for the Accurun 106 HIV antigen positive control for in vitro diagnostic use "completes the company's comprehensive series of controls" for use by blood banks in the U.S. and worldwide, the company reports Feb. 9